Biotech Values

[genisi]

Edit to my previous post

The reduction of 9.1% in death from CV, MI, or stroke was for the 2.5mg dose not both doses. The combined reduction for both doses was 8.9%.

One more point that was mentioned in theheart.org article is the number-needed-to-treat-to-benefit (NNT) - 56 (one death prevented for every 56 patients treated for two years), which is quite good.